Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC
76,600.00
-900(-1.16%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Chong Kun Dang Pharmaceutical Corp.
Address
8, Chungjeong-ro
Seoul,
Korea (the Republic of)
Phone
82 2 2194 0300
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2276
First IPO Date
December 06, 2013
Key Executives
| Name | Title | Pay | Year Born |
| Young-Joo Kim | President, Chief Executive Officer & Chairman | 710M | N/A |
| Dong-ha Lee | Finance Manager & Director | 0 | N/A |
Description
Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
